TORONTO, March 28, 2023 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) today issued a letter to shareholders from James Lanthier, Chief Executive Officer of Mindset. Dear Fellow Shareholders: Mindset saw great progress and achievements at all levels in 2022, as we worked diligently towards our ultimate goals of bringing superior…

Source

Previous articleRevive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder
Next articleField Trip’s Downfall: Too Early, Too Aggressive, Too Extravagant?